Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.

Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, Melief CJ, Cerny A.

J Exp Med. 1999 Jul 19;190(2):169-76.

2.

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.

Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakoui A, Rice CM, Kurokohchi K, et al.

J Virol. 1995 Apr;69(4):2462-70.

3.

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.

Koziel MJ, Walker BD.

Springer Semin Immunopathol. 1997;19(1):69-83. Review.

PMID:
9266632
4.

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV.

J Clin Invest. 1995 Feb;95(2):521-30.

5.

New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.

Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A.

Microbiol Immunol. 2006;50(11):857-65.

6.

CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.

Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.

J Immunol. 1995 Mar 15;154(6):2733-42.

PMID:
7533182
7.

Immunopathology of hepatitis C.

Chang KM, Rehermann B, Chisari FV.

Springer Semin Immunopathol. 1997;19(1):57-68. Review.

PMID:
9266631
9.

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.

J Hepatol. 2001 Feb;34(2):321-9.

10.

Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.

Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.

Hepatology. 2001 Jun;33(6):1533-43.

PMID:
11391544
11.

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD.

J Virol. 1993 Dec;67(12):7522-32.

12.

Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.

Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trépo C, Bain C, Lone YC, Inchauspé G, Fournillier A.

J Med Virol. 2004 Nov;74(3):397-405.

PMID:
15368525
13.

Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.

López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.

J Med Virol. 2004 Apr;72(4):575-85.

PMID:
14981760
14.
16.

Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.

Vali B, Tohn R, Cohen MJ, Sakhdari A, Sheth PM, Yue FY, Wong D, Kovacs C, Kaul R, Ostrowski MA.

J Virol. 2011 Jan;85(1):254-63. doi: 10.1128/JVI.01743-10. Epub 2010 Oct 27.

17.

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.

Shirai M, Akatsuka T, Pendleton CD, Houghten R, Wychowski C, Mihalik K, Feinstone S, Berzofsky JA.

J Virol. 1992 Jul;66(7):4098-106.

18.

The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY.

J Immunol. 1997 Feb 1;158(3):1473-81.

PMID:
9013994
19.

Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.

Ohno S, Moriya O, Yoshimoto T, Hayashi H, Akatsuka T, Matsui M.

Viral Immunol. 2006 Summer;19(3):458-67.

PMID:
16987064
20.

[A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].

Guo HZ, Wang WL, Wang T.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 May;20(3):325-7. Chinese.

PMID:
15193229

Supplemental Content

Support Center